CardioSignal presented data at ESC 2024 annual meeting on atrial fibrillation detection reliability among people suspected of various heart conditions
Posted:
CardioSignal’s CEO, co-founder, and cardiologist Juuso Blomster presented the results in the session: Transforming population health through mobile technology at the European Society of Cardiology (ESC) annual meeting that was being held in London on 30 August - 2 September.
Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) are exploring a key question in cancer immunotherapy: how to “wire” engineered natural killer (NK) cells so they respond faster and hit harder when they encounter…
SMARTWATCH screening has been shown to significantly improve atrial fibrillation detection in older, high-risk patients, with researchers reporting substantially higher diagnosis rates compared with standard care.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us